Pediatric Drug Hypersensitivity

Current Allergy and Asthma Reports
Christine R F RukasinAna Dioun Broyles

Abstract

Pediatric drug hypersensitivity is a rapidly evolving field. The purpose of this paper is to review the current state of pediatric drug hypersensitivity and highlight new developments in diagnosis and management. This paper will discuss the safety and use of risk stratification to proceed directly to oral challenge without prior skin testing for β-lactam reactions. We review unique aspects of pediatric drug challenges and desensitizations. It is important to accurately diagnose pediatric drug hypersensitivity reactions through a detailed history, physical examination, and available diagnostic testing. Understanding of the underlying mechanism leads to appropriate classification which is necessary to direct management. The decision to perform drug challenge, desensitization, or recommend avoidance of a medication can have a significant impact on a patient's treatment. Utilization of weight-based dose and infusion rate adjustments for current drug challenge and desensitization protocols optimize success.

References

Feb 1, 1983·The Journal of Pediatrics·J J HermanR Schneiderman
Jul 29, 1998·The Journal of Allergy and Clinical Immunology·A F DiounL C Schneider
Sep 19, 2003·The Journal of Allergy and Clinical Immunology·Raquel EmpedradRebecca S Gruchalla
Apr 24, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Stuart E TurveyAnahita F Dioun
Jul 9, 2004·Dermatology : International Journal for Clinical and Investigative Dermatology·Yuichi Teraki, Tetsuo Shiohara
Oct 6, 2004·Allergy·A RomanoUNKNOWN EAACI
Aug 17, 2006·The Annals of Pharmacotherapy·Daren LinMichael J Rieder
Aug 29, 2006·Brain & Development·Seiko ItomiKazuyoshi Watanabe
Oct 3, 2007·Pediatrics·Alissa R SegalBarrett Zlotoff
Dec 21, 2007·Clinical Reviews in Allergy & Immunology·Tetsuo Shiohara, Yoko Kano
Jan 15, 2008·The Journal of Allergy and Clinical Immunology·Carla M Davis, William T Shearer
Jan 9, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R MirakianUNKNOWN BSACI
May 8, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Abdelbaset A ElzagallaaiGideon Koren
Jul 1, 2009·Immunology and Allergy Clinics of North America·Mariana Castells
Nov 17, 2009·The Journal of Pediatrics·Diego G PeroniAttilio L Boner
Jan 30, 2010·The Journal of Allergy and Clinical Immunology·Scott H Sicherer, Donald Y M Leung
Mar 5, 2010·The Journal of Allergy and Clinical Immunology·David A Khan, Roland Solensky
Jun 24, 2010·European Journal of Pediatrics·Hans de Groot, W M C Mulder
Aug 19, 2010·Allergy·J R CernadasUNKNOWN European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity
Oct 12, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·UNKNOWN Joint Task Force on Practice ParametersUNKNOWN Joint Council of Allergy, Asthma and Immunology
Nov 3, 2010·The Journal of Allergy and Clinical Immunology·Jean-Christoph CaubetPhilippe A Eigenmann
Dec 31, 2010·The Journal of Allergy and Clinical Immunology·Scott H Sicherer, Donald Y M Leung
Mar 2, 2011·European Journal of Immunology·Maria del Carmen Sancho-SerraMariana Castells
Sep 3, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A LiuM Castells
Dec 6, 2011·Current Allergy and Asthma Reports·Anahita Falakshahi Dioun
May 23, 2012·The Journal of Allergy and Clinical Immunology·John M KelsoDana Wallace
Nov 3, 2012·The Journal of Allergy and Clinical Immunology·David A Khan
Feb 5, 2013·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Mustafa ErkoçoğluCan Naci Kocabas
Mar 20, 2013·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Maria A ZamboninoJose L Corzo
Apr 4, 2013·International Archives of Allergy and Immunology·K RutkowskiS M Nasser
May 28, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·John M Kelso
Jun 12, 2013·Allergy·K SchererUNKNOWN ENDA, the European Network on Drug Allergy and the EAACI Drug Allergy Interest Group
Oct 31, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Jobst Fridolin RoehmelDoris Staab
Nov 2, 2013·The World Allergy Organization Journal·Mario Sánchez-BorgesMaria José Torres Jaén
Jan 15, 2014·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Stephanie LogsdonAnahita Dioun
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·David I Hong, Anahita F Dioun
Apr 5, 2014·Allergy·P DemolyB Y- H Thong
Jul 16, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Stephanie J Fox, Miguel A Park
Sep 10, 2014·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Semanur KuyucuKnut Brockow
Oct 5, 2014·The Journal of Allergy and Clinical Immunology·Elina JerschowAileen P McGinn
Dec 4, 2014·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Jean-Christoph CaubetPhilippe A Eigenmann
Jan 28, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R MirakianUNKNOWN Standards of Care Committee of the British Society for Allergy and Clinical Immunology
Sep 30, 2015·Allergy·Eva GomesUNKNOWN ENDA/EAACI Drug Allergy Interest Group
Dec 2, 2015·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Emine VezirCan N Kocabas
Dec 19, 2015·Allergy·A OussalahUNKNOWN Task force ‘Genetic predictors of drug hypersensitivity’ of the European Network on Drug Allergy (ENDA) of EAACI

❮ Previous
Next ❯

Citations

Feb 7, 2020·Clinical and Experimental Pediatrics·Ji Soo Park, Dong In Suh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Immunology and Allergy Clinics of North America
Mariana Castells
Current Opinion in Allergy and Clinical Immunology
Mariana Castells
Current Opinion in Allergy and Clinical Immunology
Paul WhitakerDaniel Peckham
Clinical Reviews in Allergy & Immunology
Scott D Dickson, Kimberly C Salazar
The Journal of Allergy and Clinical Immunology. in Practice
Mariana Castells
© 2022 Meta ULC. All rights reserved